Market Closed -
Other stock markets
|
Pre-market 09:21:52 am | |||
34.42 USD | +1.59% | 34.28 | -0.41% |
Mar. 18 | Newmont Corporation(ASX:NEM) dropped from S&P/ASX 20 Index | CI |
Mar. 06 | Newmont Prices $2 Billion Bonds | MT |
Financials (USD)
Sales 2024 * | 16.03B | Sales 2025 * | 17.26B | Capitalization | 39.69B |
---|---|---|---|---|---|
Net income 2024 * | 2.09B | Net income 2025 * | 2.72B | EV / Sales 2024 * | 2.76 x |
Net Debt 2024 * | 4.52B | Net Debt 2025 * | 3.76B | EV / Sales 2025 * | 2.52 x |
P/E ratio 2024 * |
18.7
x | P/E ratio 2025 * |
14.4
x | Employees | 21,700 |
Yield 2024 * |
3.75% | Yield 2025 * |
3.74% | Free-Float | 99.27% |
Latest transcript on Newmont Corporation
1 day | +1.59% | ||
1 week | -2.33% | ||
Current month | +10.14% | ||
1 month | +2.96% | ||
3 months | -16.23% | ||
6 months | -14.95% | ||
Current year | -16.84% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Palmer
CEO | Chief Executive Officer | 56 | 14-03-13 |
Karyn Ovelmen
DFI | Director of Finance/CFO | 60 | 23-05-29 |
Brian Tabolt
DFI | Director of Finance/CFO | 42 | 21-03-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Boyce
CHM | Chairman | 69 | 15-10-26 |
Maura Clark
BRD | Director/Board Member | 65 | 20-03-31 |
Mary Laschinger
BRD | Director/Board Member | 64 | 21-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.29% | 281 M€ | -.--% | ||
14.50% | 227 M€ | +9.20% | - | |
13.05% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 34.42 | +1.59% | 14,967,416 |
24-03-15 | 33.88 | -0.96% | 53,029,563 |
24-03-14 | 34.21 | -0.47% | 18,926,696 |
24-03-13 | 34.37 | +1.45% | 15,764,634 |
24-03-12 | 33.88 | -3.86% | 14,192,165 |
Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.84% | 39.69B | |
+0.82% | 27.5B | |
-11.57% | 27.44B | |
-8.54% | 20B | |
+1.39% | 10.28B | |
+13.27% | 8.93B | |
-.--% | 8.64B | |
-8.90% | 7.24B | |
-4.61% | 6.93B | |
+1.68% | 5.31B |